Sign In
Buy AAPG
Ascentage Pharma Group Internat Stock Insider Power
Based on the 71 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 4.91M and sold 0 AAPG shares in the last 71 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
100.00 |
| ● Buy | 4.91M shares |
| ● Sell | 0 shares |
|
100% Buy Activity
Weak Negative Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 21, 2026 Buy |
Yang Dajun Chairman And CEO |
92 746 Value: $1.92M |
||
|
May 21, 2026 Buy |
Yang Dajun Chairman And CEO |
92 746 Value: $1.92M |
||
|
May 21, 2026 Buy |
Yang Dajun Chairman And CEO |
95 575 Value: $1.97M |
||
|
May 21, 2026 Buy |
Zhai Yifan Chief Medical Officer |
95 575 Value: $1.97M |
||
|
May 21, 2026 Buy |
Zhai Yifan Chief Medical Officer |
92 746 Value: $1.92M |
||
|
May 21, 2026 Buy |
Zhai Yifan Chief Medical Officer |
95 575 Value: $1.97M |
||
|
May 20, 2026 Buy |
Yang Dajun Chairman And CEO |
298 195 Value: $5.90M |
||
|
May 20, 2026 Buy |
Yang Dajun Chairman And CEO |
92 746 Value: $1.83M |
||
|
May 20, 2026 Buy |
Yang Dajun Chairman And CEO |
95 575 Value: $1.89M |
||
|
May 20, 2026 Buy |
Yang Dajun Chairman And CEO |
103 364 Value: $839.3K |
||
|
May 20, 2026 Buy |
Yang Dajun Chairman And CEO |
103 365 Value: $2.04M |
||
|
May 20, 2026 Buy |
Yang Dajun Chairman And CEO |
214 988 Value: $1.41M |
||
|
May 20, 2026 Buy |
Yang Dajun Chairman And CEO |
214 999 Value: $4.25M |
||
|
May 20, 2026 Buy |
Yang Dajun Chairman And CEO |
298 194 Value: $1.96M |
||
|
May 20, 2026 Buy |
Zhai Yifan Chief Medical Officer |
92 746 Value: $1.83M |
||
|
May 20, 2026 Buy |
Zhai Yifan Chief Medical Officer |
95 575 Value: $1.89M |
||
|
May 20, 2026 Buy |
Zhai Yifan Chief Medical Officer |
103 364 Value: $839.3K |
||
|
May 20, 2026 Buy |
Zhai Yifan Chief Medical Officer |
103 365 Value: $2.04M |
||
|
May 20, 2026 Buy |
Zhai Yifan Chief Medical Officer |
214 988 Value: $1.41M |
||
|
May 20, 2026 Buy |
Zhai Yifan Chief Medical Officer |
214 999 Value: $4.25M |
||
|
May 20, 2026 Buy |
Zhai Yifan Chief Medical Officer |
298 194 Value: $1.96M |
||
|
May 20, 2026 Buy |
Zhai Yifan Chief Medical Officer |
298 195 Value: $5.90M |
||
|
Apr 20, 2026 Buy |
Misra Veet Chief Financial Officer |
18 584 Value: $489.9K |
||
|
Mar 18, 2026 Buy |
Misra Veet Insider |
0 Value: $0 |
||
|
Mar 18, 2026 Buy |
Cao Jin Chief Accounting Officer |
0 Value: $0 |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
